<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01940224</url>
  </required_header>
  <id_info>
    <org_study_id>UTH2828/26/06/2013</org_study_id>
    <nct_id>NCT01940224</nct_id>
  </id_info>
  <brief_title>Evaluation of Preoperative Use of Pregabalin on Postoperative Analgesia After Laparoscopic Colorectal Surgery</brief_title>
  <official_title>Effectiveness of Preemptive Use of Pregabalin on Pain Intensity and Postoperative Morphine Consumption After Laparoscopic Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Larissa University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Thessaly</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Larissa University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how effective is the preoperative administration of
      pregabalin 300mg, to attenuate postoperative pain and opioids consumption after laparoscopic
      colorectal surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic colorectal surgery has gained wide acceptance because it is associated with
      reduced pain, lower morbidity, faster recovery and a shorter hospital stay. However, the
      optimal postoperative pain management method for patients undergoing laparoscopic colorectal
      surgery is still under evaluation and most of the recommendations are based on studies
      performed in open approach procedures.

      Recently, the analgesic effect of pregabalin, as a part of a multimodal analgesia, has been
      evaluated in many studies. They have shown that pregabalin may have a role in the post
      operative pain management, as an adjunct. Pregabalin is an anticonvulsant and anxiolytic
      drug, which have a more favorable pharmacokinetic profile from its predecessor gabapentin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>The total dose of morphine was calculated as mg and administered by PCA pump. Postoperative morphine requirements were assessed on the arrival of the patient to the recovery room (0hrs),8 hrs,24 hrs until the completion of 48 hours after operation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>48 hours</time_frame>
    <description>NRS = numeric rating scale 0-10 mm (0=no pain to 10= worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side- effects</measure>
    <time_frame>48 hours</time_frame>
    <description>To determine the occurrence of side effects such as postoperative nausea,vomiting, itching, headache, dizziness, blurred vision, lack of concentration, shoulder pain, sedation, and respiratory depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 1 week</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Pregabalin &amp; Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of pregabalin 300 mg to patients undergo laparoscopic colorectal surgery.Patients receive oral Pregabalin 150 mg the night before surgery, and another one dose of 150 mg 1 hour prior to surgery. Postoperative administration of morphine via PCA pump for 48 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo &amp; Morphine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of placebo to patients undergo laparoscopic colorectal surgery.Patients receive oral Placebo the night before surgery, and another one dose 1 hour prior to surgery.Postoperative administration of morphine via PCA pump for 48 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Preoperative administration of pregabalin 300mg</description>
    <arm_group_label>Pregabalin &amp; Morphine</arm_group_label>
    <other_name>Lyrica</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Preoperative administration of placebo</description>
    <arm_group_label>Placebo &amp; Morphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Postoperative administration of morphine via PCA pump for 48h</description>
    <arm_group_label>Placebo &amp; Morphine</arm_group_label>
    <arm_group_label>Pregabalin &amp; Morphine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I-III

          -  Patients who undergo laparoscopic colectomy for benign or malignant colorectal disease
             ( &lt;Î¤3 or =T3 tumors without distant metastasis )

        Exclusion Criteria:

          -  Contraindication for pneumoperitoneum

          -  Contraindication for laparoscopic approach

          -  Renal or hepatic insufficiency

          -  Alcohol or drugs abuse

          -  History of chronic pain or daily intake of analgesics

          -  Psychiatric disorders

          -  Inability of patients to use PCA pump History of intake of non-steroidal
             anti-inflammatory drugs the last 24 hours before surgery,use of drainage after the
             surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Theodorou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Larissa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>George Tzovaras, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital of Larissa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgia Stamatiou, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital of Larissa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <zip>41100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>August 30, 2013</study_first_submitted>
  <study_first_submitted_qc>September 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2013</study_first_posted>
  <last_update_submitted>February 25, 2019</last_update_submitted>
  <last_update_submitted_qc>February 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Larissa University Hospital</investigator_affiliation>
    <investigator_full_name>Elena Theodorou</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Pregabalin</keyword>
  <keyword>Laparoscopic colorectal surgery</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Opioid consumption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

